Kenneth G. Schuler

Marc N. Zubick

Terrence J. Connolly

Michelle P. Woodhouse

Parker M. Tresemer

Steven J. Fineman

Michelle R. Ma

Katharine L. Mowery

Lesley Hamming

Sarah R. Frazier

Kevin S. Prussia

Lisa J. Pirozzolo

Caitlin Looby

Michael P. Kelly

Daniel M. Silver

Benjamin A. Smyth

Timothy A. Cook

Kelli Powell

Jeffrey S. Olshan

Lauren V. Blakely

Kelly Halford

Actavis's generic JADENU® challenge concedes infringement, sparking a Novartis suit over its `pharmaceutical metal chelator` patent for iron overload therapy.

Prosecution History analysis

Examiner Search analysis

Invalidity Framework analysis

Name	Ratings
Novartis Pharmaceuticals Corp	L4 A
Novartis Pharma AG	L4 A
Novartis Corp	L4 A
Novartis AG	L4 A

Name	Ratings
Wilmer Cutler Pickering Hale Dorr LLP	L5 A
Kevin S. Prussia	L2 C
Kelli Powell	L1 D
Sarah R. Frazier	L1 D
Timothy A. Cook	-- -- --
Kelly Halford	-- -- --
McCarter & English LLP	L4 A
Daniel M. Silver	L5 A
Lisa J. Pirozzolo	L5 A
Michael P. Kelly	L4 A
Benjamin A. Smyth	L3 A
Caitlin Looby	L1 C
Jeffrey S. Olshan	-- -- --
Lauren V. Blakely	-- -- --

Name	Ratings
Actavis Inc	L5 E
Actavis Elizabeth LLC	L5 E

Name	Ratings
Richards Layton & Finger PALocal	L5 E
Steven J. Fineman	L5 E
Katharine L. Mowery	L4 E
Latham & Watkins LLP	L4 A
Kenneth G. Schuler	L4 E
Marc N. Zubick	L3 D
Michelle P. Woodhouse	L2 C
Michelle R. Ma	L2 D
Terrence J. Connolly	L2 E
Lesley Hamming	L2 E
Parker M. Tresemer	L1 B

1:15-cv-01219

Novartis Pharma Corp v. Actavis Inc